• MIHIR OTIA

For the purpose of administering medication, a transdermal patch dispenses the medication as an adhesive patch applied directly on the skin. This frequently aids in the recovery of a damaged bodily part. To compare transdermal drug delivery to other methods of administering medication like oral or topical or intravenously or intramuscularly is to note that the patch delivers medication into the patient in two ways: either by using a porous membrane to seal in the medication or by using body heat to melt thin layers of medication embedded in the adhesive. In contrast to other dosage forms, transdermal medication delivery provides a controlled release of the medicine into the patient, allowing for a stable blood level profile and reducing systemic side effects. With transdermal drug delivery systems, the goal is to deliver medications into circulation at a predefined pace with little fluctuation between and among patients via the skin. This is both a fascinating and difficult field to work in. In the present day and age, there are a large number of transdermal delivery methods on the market. The transdermal market, on the other hand, is still restricted to a small number of medications. The capacity to overcome the problems related to drug molecule penetration and skin irritation will be critical in furthering transdermal delivery advancements. The introduction of new ways for improving skin penetration and the development of approaches to reduce skin irritation will broaden the transdermal market for hydrophilic chemicals, macromolecules, and conventional pharmaceuticals for new therapeutic purposes.. Transdermal medication administration has a bright future, as evidenced by the numerous clinical trials currently being conducted on a wide range of pharmaceuticals for a number of clinical problems.

Transdermal, Epidermis, Matrix, Reservoir , Clinical trials

"A Review of Nanoformulations for transdermal delivery challenges and opportunities ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 11, page no.a26-a43, November-2021, Available :http://www.jetir.org/papers/JETIR2111006.pdf

"A Review of Nanoformulations for transdermal delivery challenges and opportunities ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 11, page no. ppa26-a43, November-2021, Available at : http://www.jetir.org/papers/JETIR2111006.pdf